Rockefeller Capital Management L.P. Horizon Therapeutics Public LTD CO Transaction History

Rockefeller Capital Management L.P.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $219,655 - $256,226	-2,280 Reduced 25.24%	6,755 $694,000
Q1 2023 May 17, 2023	SELL	$107.32 - $113.5 $9.99 Million - $10.6 Million	-93,069 Reduced 91.15%	9,035 $985,000
Q4 2022 Mar 06, 2023	BUY	$62.39 - $113.8 $6.23 Million - $11.4 Million	99,791 Added 4314.35%	102,104 $11.6 Million
Q3 2022 Nov 02, 2022	SELL	$58.92 - $84.67 $93,034 - $133,693	-1,579 Reduced 40.57%	2,313 $143,000
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $142,046 - $208,168	1,789 Added 85.07%	3,892 $309,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $152,012 - $193,155	1,759 Added 511.34%	2,103 $220,000
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $6,209 - $7,554	63 Added 22.42%	344 $36,000
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $55,973 - $67,215	-609 Reduced 68.43%	281 $29,000
Q2 2021 Aug 10, 2021	SELL	$86.24 - $95.92 $10,003 - $11,126	-116 Reduced 11.53%	890 $82,000
Q1 2021 May 11, 2021	SELL	$71.83 - $95.48 $109,253 - $145,225	-1,521 Reduced 60.19%	1,006 $92,000
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $98,309 - $142,275	1,780 Added 238.29%	2,527 $195,000
Q2 2020 Aug 12, 2020	SELL	$30.2 - $56.98 $4,590 - $8,660	-152 Reduced 16.91%	747 $42,000
Q4 2019 Feb 07, 2020	BUY	$25.43 - $36.67 $1,347 - $1,943	53 Added 6.26%	899 $33,000
Q3 2019 Nov 12, 2019	SELL	$23.0 - $27.97 $1,311 - $1,594	-57 Reduced 6.31%	846 $23,000
Q2 2019 Aug 09, 2019	BUY	$22.81 - $28.48 $20,597 - $25,717	903 New	903 $22,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.